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ABSTRACT
Converging evidence has suggested that anandamide (AEA),
an endogenous agonist of cannabinoid (CB) receptors, can
directly interact with certain types of ligand-gated ion channels
(LGICs). However, little is known about the molecular and
cellular mechanisms of AEA-induced direct effects on LGICs.
Here, we report that AEA inhibited the function of serotonin-
gated ion channels (5-HT3A) expressed in Xenopus laevis
oocytes and human embryonic kidney 293 cells in a manner
that was dependent on the steady-state receptor density at the
cell surface. The magnitude of AEA inhibition was inversely
correlated with the expression levels of receptor protein and
function. With increasing surface receptor expression, the mag-
nitude of AEA inhibition decreased. Consistent with this idea,
pretreatment with actinomycin D, which inhibits transcription,
decreased the amplitude of current activated by maximal con-
centrations of 5-hydroxytryptamine (5-HT) and increased the
magnitude of AEA inhibition. AEA did not significantly alter
5-HT3A receptor trafficking. However, AEA accelerated 5-HT3A
receptor desensitization time in a concentration-dependent
manner without significantly changing receptor activation and
deactivation time. The desensitization time was correlated with
the AEA-induced inhibiting effect and mean 5-HT current den-
sity. Applications of 5-hydroxyindole and nocodazole, a micro-
tubule disruptor, significantly slowed 5-HT3A receptor desensi-
tization and reduced the magnitude of AEA inhibition. These
observations suggest that 5-HT3 receptor density at the steady
state regulates receptor desensitization kinetics and the po-
tency of AEA-induced inhibiting effect on the receptors. The
inhibition of 5-HT3 receptors by AEA may contribute to its
physiological roles in control of pain and emesis.
The endocannabinoid anandamide (AEA) is synthesized
from lipid precursors in cell membranes via calcium- and
G-protein-dependent processes. Rapidly released from neu-
rons after membrane depolarization, AEA can modulate
many brain functions by preferentially activating presynap-
tic cannabinoid type 1 (CB1) receptors (Pacher et al., 2006).
However, accumulating evidence has indicated that there
are additional molecular sites that may mediate AEA action
in the central and peripheral nervous system. AEA has also
been found to directly modulate the function of various
ligand-gated ion channels (LGICs) such as the serotonin type
3 (5-HT3) receptors, nicotinic acetylcholine (nACh) 7 and
42 subunits and glycine receptors (Fan, 1995; Barann et
al., 2002; Oz et al., 2002, 2003; Hejazi et al., 2006; Spivak et
al., 2007). Moreover, some AEA-induced behavioral effects
are not mediated by activation of CB1 receptors. For example,
AEA can induce catalepsy and analgesia in CB1 knockout
mice (Zimmer et al., 1999). AEA has been found to attenuate
neuronal excitability and pain via a CB1-independent mech-
anism in mice (Adams et al., 1998).
5-HT3 receptors are involved in pain transmission, analge-
sia, mood disorders, and drug abuse (Zhang and Lummis,
2006). Selective 5-HT3 receptor antagonists have anxiolytic
and antiemetic effects in human and in animal models
(Zhang and Lummis, 2006). The levels of 5-HT3A receptors
are differentially expressed in brain regions and subpopula-
tions of neurons (Tecott et al., 1993; Morales and Bloom,
1997; Spier et al., 1999; Morales and Wang, 2002). Although
high levels of 5-HT3 receptors are found in nucleus of the
tractus solitarius and area postrema, low levels of the re-
ceptors are expressed in nucleus accumbens and striatum
(Waeber et al., 1988, 1989, 1990; Barnes et al., 1989; Pratt et
al., 1990; Tecott et al., 1993; Morales and Bloom, 1997).
Overexpression of 5-HT3A receptors in mouse forebrain in-
creases the sensitivity to alcohol-induced behavioral effects
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and enhances hippocampal-dependent learning and atten-
tion (Engel et al., 1998; Engel and Allan, 1999; Harrell and
Allan, 2003). Several naturally occurring polymorphisms in
human 5-HT3A receptors can significantly change the levels
of receptor expression at cell membrane surfaces (Niesler et
al., 2001a; Krzywkowski et al., 2007). These mutations are
found to associate with affective disorders, the personality
trait of harm avoidance, human face processing and emeto-
genic sensitivity to anticancer drug-induced side effects such
as vomiting and nausea (Niesler et al., 2001a,b; Melke et al.,
2003; Iidaka et al., 2005; Krzywkowski, 2006).
Despite evidence showing that AEA can directly modulate
a variety of ion channel functions, the molecular and cellular
mechanisms of the AEA-induced CB1-independent effects
remain elusive. AEA has been shown to inhibit the 5-HT3A
receptor-mediated responses in rat nodose ganglion (NG)
neurons and in cell lines expressing mouse and human
5-HT3A subunits (Fan, 1995; Barann et al., 2002; Oz et al.,
2002). However, the potency of AEA inhibition has been
found to vary significantly among different cell lines.
Whereas AEA inhibits 5-HT3 responses with an EC50 value
of 0.19 M in NG neurons, the EC50 value of AEA inhibition
is 3.7 M in Xenopus laevis oocytes expressing homomeric
5-HT3A receptors (Fan, 1995; Oz et al., 2002). This discrep-
ancy is unlikely because of different compositions of the
5-HT3 subunits that are expressed in native neurons and in
heterologous expression systems because the potency of AEA
inhibition of homomeric 5-HT3A receptors is similar to that of
native receptors expressed in HEK293 cells and NG neurons
(Fan, 1995; Barann et al., 2002; Oz et al., 2002). One alter-
native explanation is that the discrepancy may arise from
different levels of receptor expression. To test this hypothe-
sis, we examined the relationships between the extent of the
AEA inhibition of 5-HT3A receptors and receptor density at
the cell surface. Our results suggest that the steady-state
density of 5-HT3 receptors critically influences on receptor
desensitization and the sensitivity of 5-HT3 receptors to
AEA-induced inhibiting effect.
Materials and Methods
Preparation of cRNAs and Expression of Receptors. The
cDNA clone of the mouse 5-HT3A subunit was provided by Dr. David
Julius (University of California, San Francisco, CA). The cDNA clone
of the human 5-HT3A subunit was purchased from OriGen, Inc
(Rockville, MD). Complementary RNAs (cRNAs) were synthesized in
vitro using a mMessage mMachine RNA transcription kit (Ambion
Inc., Austin, TX). The quality and sizes of synthesized cRNAs were
confirmed by denatured RNA agarose gels. Mature female X. laevis
frogs were anesthetized by submersion in 0.2% 3-aminobenzoic acid
ethyl ester (Sigma, St. Louis, MO). Oocytes were surgically excised
and separated. The follicular cell layer of the oocytes was removed by
treatment with type A collagenase (Sigma-Aldrich) for 10 min at
room temperature. Although the amount of cRNA injected into oo-
cytes varied from 1 to 100 ng, as indicated, the injection volume of
diethylpyrocarbonate-treated water was kept in 20 nl throughout the
entire experiment. Oocytes were incubated at 19°C in modified
Barth’s solution: 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 2.0 mM
CaCl2, 0.8 mM MgSO4, and 10 mM HEPES, pH7.4.
X. laevis Oocyte Electrophysiological Recording. After incu-
bation for 2 to 5 days, oocytes were studied at room temperature
(20–22°C) in a 90-l chamber. The oocytes were superfused with
modified Barth’s solution at a rate of 6 ml/min. Agonists and chem-
ical agents were diluted in the bath solution and applied to the
oocytes for a specified time, using a solenoid valve-controlled super-
fusion system. Membrane currents were recorded by two-electrode
voltage-clamp at a holding potential of 70 mV, using a GeneClamp
500 amplifier (Molecular Devices, Sunnyvale, CA). The recording
microelectrodes were filled with 3 M KCl and had electrical resis-
tances of 0.5 to 3.0 M. Data were acquired using pClamp 9.1
software (Molecular Devices). Average values are expressed as
means  S.E.
Western Blot of Membrane Surface Proteins. Immediately
after treatment with AEA, X. laevis oocytes expressing 5-HT3A re-
ceptors were washed in PBS and incubated with N-hydroxysuccin-
imide-SS-biotin (Pierce, Rockford, IL) at a concentration of 1.5 mg/ml
in phosphate-buffered saline (PBS) for 30 min at 4°C under nonper-
meabilizing conditions, as described previously (Hollmann et al.,
1994; Lan et al., 2001). The oocytes were then washed and homoge-
nized. The homogenate was centrifuged repeatedly at 1000g for 10
min at 4°C until all yolk granules and melanosomes were pelleted.
The final supernatant was incubated with 100 l of neutravidin-
linked beads (Pierce) by end-over-end rotation for 2 h at 4°C. The
beads were centrifuged and washed extensively to isolate bead-
bound proteins. Labeled proteins were eluted from the beads by
dithiothreitol-containing SDS-PAGE loading buffer and loaded onto
10% SDS/PAGE. After transfer onto a PVDFmembrane (Invitrogen),
the surface proteins were blocked with PBS, pH 7.5, containing 0.1%
Tween 20 (Sigma) and 5% nonfat powdered milk and then incubated
for 1 h with a polyclonal antibody (pAb120, 1:2000) directed to the
extracellular N-terminal domain of the 5-HT3A receptor (Spier et al.,
1999). The proteins were washed, blotted with a 1:600 dilution of
fluorescein-linked anti-rabbit Ig in PBS, and incubated with anti-
fluorescein-alkaline phosphatase conjugate (Pierce) at 1:2500 dilu-
tion in PBS for 1 h. The proteins detected by ECF substrate (GE
Healthcare) were scanned using a Storm Gel and Blot Imaging
System with ImageQuant image analysis software (GE Healthcare).
HEK 293 Cell Transfection and Whole Cell Recording. HEK
293 cells were cultured as described previously (Hu et al., 2006). The
plasmid cDNA of human 5-HT3A receptors was transfected with
SuperFect Transfection kit (QIAGEN, Valencia, CA). The currents
were recorded 24 to 48 h after transfection. Cells were lifted and
continuously superfused with a solution containing 140 mM NaCl, 5
mM KCl, 1.8 mM CaCl2, 1.2 mM MgCl2, 5 mM glucose, and 10 mM
HEPES, pH 7.4, with NaOH; 340 mOsmol with sucrose). Mem-
brane currents were recorded in the whole-cell configuration using
an Axopatch 200B amplifier (Molecular Devices) at 20 to 22°C. Cells
were held at60 mV unless otherwise indicated. Data were acquired
using pClamp 9 software (Molecular Devices). Bath solutions were
applied through three-barrel square glass tubing (Warner Instru-
ment, Hamden, CT) that had been pulled to a tip diameter of 200
m. Drugs were applied through Warner fast-step stepper-motor
driven system. The 10 to 90% rise time of the junction potential at
whole-cell recording was 4 to 12 ms.
Staining and Imaging of 5-HT3A Receptor -Bungarotoxin
(BTX)-Tag Transfected in HEK 293 Cells. To generate 5-HT3A
receptor-BTX-tag, two copies of the sequence 5-TGGCGGTAC-
TACGAGAGCAGCCTGGAGCCCTACCCCGAC-3 were inserted into
both 5 and 3 ends of the 5-HT3A subunit subcloned in pCDNA 3.1
() using polymerase chain reaction amplification. The 5-HT3A-BTX-
tag was transfected into HEK 293 cells using Lipofectamine 2000
(Invitrogen, Carlsbad, CA). 24 to 48 h after transfection, living cells
were stained with tetramethylrhodamine-BTX at 1 g/ml (Invitro-
gen) for 5 min at room temperature. Cells were washed twice with
PBS and then incubated with 2 M AEA for 5 min. Cells were
stained with Alexa Fluor 488-BTX at 1 g/ml for 5 min, washed and
fixed with 4% paraformaldehyde. Cells were rinsed with PBS and
mounted in a glycerol-based mounting medium. Cells were imaged
with a CCD camera attached to a Zeiss Axiovert epifluorescence
microscope. The Alexa Fluor 488 was excited at 480/35 nm and the
emission of light was collated using a 533/35 emission filter with a
1.3 numerical aperture 100 objective. The tetramethylrhodamine
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was excited at 540/25 nm and the emission of light was collected
using a 605/55 emission filter.
Data Analysis. Statistical analysis of concentration-response
data were performed with the use of the nonlinear curve-fitting
program Prism. Data were fit using the Hill equation: I/Imax 
1/[1 (EC50/[Agonist])
nH], where I is the current amplitude activated
by a given concentration of agonist ([Agonist]), Imax is the maximum
response of the cell, nH is the Hill coefficient, and EC50 is the
concentration eliciting a half-maximal response. Data were statisti-
cally compared by the paired t test, or analysis of variance (ANOVA),
as noted. Average values are expressed as mean  S.E.
Kinetic Analysis. Receptor activation rate was induced by 30 M
5-HT and estimated by measuring the slope of the initial inward
component of current between 10 and 30% of the maximal current
(10%–30% rise time). Receptor desensitization was induced by pro-
longing incubation with AEA for 30 s. The deactivation time was
recorded for 30 s immediately after a brief application of 1 mM 5-HT
for 5 ms. The time constants of deactivation and desensitization
were determined by fitting with exponential functions using the
Marquardt-Levenberg algorithm in Clampfit. The deactivation and
desensitization time constants for 5-HT3-mediated currents were
best fit using a biexponential function when expressed in HEK 293
cells. However, a single exponential function was sufficient to accu-
rately fit the desensitization decays of current activated by 5-HT in
the presence of AEA. In this case, fast and slow components were
normalized from two components to single component following the
equation: (AFAST  FAST  ASLOW  SLOW), where as FAST and
SLOW were the fast and slow decay time constants, and AFAST and
ASLOW were the relative proportion of the fast and slow components.
Chemicals. All chemicals used in preparing the solutions were
from Sigma-Aldrich (St. Louis, MO). 5-HT was applied by gravity
flow via a micropipette positioned 3 mm from the oocyte. Stock
solutions of AEA, 5-hydroxyindole (5-HTID), and nocodazole (NOC)
were prepared in dimethyl sulfoxide (DMSO) at a concentration of 10
mM. DMSO alone did not affect 5-HT receptor-mediated current
when added at concentrations up 0.2% (v/v), which was twice as high
as the most concentrated DMSO used in our experiments.
Results
AEA Inhibition Was Independent of Agonist Concen-
trations. Consistent with a previous observation (Oz et al.,
2002), incubation of AEA (10 M) for 10 to 20 min produced
gradually developing inhibition of 5-HT (1 M)-induced cur-
rents in X. laevis oocytes previously injected with 2.5 ng of
the mouse 5-HT3A subunit cRNA (Fig. 1A). The AEA-induced
inhibition reached a maximum of 86% after a 10-min expo-
sure and was completely reversed 30 min after discontinua-
tion of drug application (Fig. 2B). The inhibition by AEA was
concentration-dependent with an EC50 value of 239  13 nM
and slope value of 0.8  0.16 (Fig. 1C). The effect of 10 M
AEA on 5-HT3A receptors was also studied in the presence of
different concentrations of 5-HT. The inhibition by AEA was
equipotent at all agonist concentrations (Fig. 1D). The EC50
and slope values of the 5-HT-concentration response curves
were 1.6  0.05 M and 1.5  0.2 in the absence of AEA, and
1.9  0.2 M and 1.8  1.0 in the presence of 10 M AEA.
These values were not significantly different (p 	 0.2, un-
paired t test, n  5).
AEA Inhibition Correlated with Receptor Surface
Protein and Function. To examine whether the AEA inhi-
bition depends on surface receptor density, we injected vari-
ous concentrations (1, 2.5, 10, 25, 50, and 75 ng) of mouse
5-HT3A subunit cRNA into X. laevis oocytes. We first mea-
sured the surface expression of 5-HT3A receptors in oocytes
using Western blots by labeling cell-surface proteins with
sulfo-N-hydroxysuccinimide-SS-biotin (Lan et al., 2001). Fig-
ure 2A reveals a representative Western blot of surface re-
ceptor proteins from cells injected with 50, 10, and 1 ng of
5-HT3A receptor cRNA. The amplitude of current activated
by 100 M 5-HT also increased with increasing cRNA injec-
tion levels (Fig. 2B). AEA at 10 M inhibited 5-HT3A recep-
tor-mediated current in a manner that depended on the ex-
pression levels of surface receptor protein (Fig. 2, B and C).
The magnitude of AEA inhibition was strongest at lower
receptor expression levels. For instance, the maximal AEA
inhibition was 95% (5  2% of control) in oocytes injected
with 2.5 ng of 5-HT3A receptor cRNA, whereas the maximal
inhibition was only 25% (75  6% of control) in oocytes
injected with 50 ng of 5-HT3A receptor cRNA. These values
were significantly different (Fig. 2C; unpaired t test, p 

0.001). The EC50 values of AEA inhibition differed by nearly
120-fold between oocytes previously injected with 1 and 50 ng
of cRNAs (Fig. 2D). For instance, the EC50 value for AEA
inhibition was 167  12 nM in cells injected with 1 ng of
cRNA, whereas the EC50 value for AEA inhibition was 20 
2 M in cells injected with 50 ng of cRNA. These values were
significantly different (Fig. 2D; p 
 0.001, unpaired t test,
n  5). The magnitude of inhibition produced by 10 M AEA
was strongly correlated with the amount of the cRNA in-
jected into the oocytes (Fig. 3A; p 
 0.0001), the expression
level of the receptor proteins (Fig. 3B; p 
 0.0001) and the
Fig. 1. AEA inhibition of I5-HT in X. laevis oocytes expressing 5-HT3A
receptors. A, AEA inhibition of I5-HT. Tracing records showing currents
activated by 1 M 5-HT in the absence and presence of 10 M AEA. The
solid bar on the top of each trace record represents the time of 5-HT
application. A long solid bar indicates the time of continuous application
of AEA. B, time course of AEA inhibition of I5-HT in cells previously
injected with 2.5 ng of cRNA of mouse 5-HT3A subunit. The solid bar
indicates the application time of 10 M AEA. Each data point represents
mean  S.E. from at least seven oocytes. Error bars are omitted if they
were smaller than the size of symbols. C, the concentration-response
curve of AEA inhibition of I5-HT in oocytes previously injected with 2.5 ng
of cRNA of the mouse 5-HT3A subunit. The curve is best fit to the Hill
equation as described under Materials and Methods. Each data point
represents mean  S.E. from at least seven oocytes. D, noncompetitive
inhibition of 5-HT3A receptor-mediated responses by AEA. 5-HT concen-
tration-response curves in the absence (E) and in the presence of 10 M
AEA (F).
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maximal current activated by 100 M 5-HT (Fig. 3C; p 
0.002).
AcD Increased AEA Inhibition. To further confirm the
relationship between receptor density and AEA inhibition,
we preincubated oocytes with 10 g/ml AcD, which inhibits
RNA transcription, for 24 h before recordings. We observed
that AcD significantly reduced current amplitude activated
by 100 M 5-HT from 7.8  2.5 to 1.4  0.4 A (Fig. 4A; p 

0.001, unpaired t test, n  7). This suggests that AcD can
reduce the functional expression of 5-HT3A receptors. On the
other hand, AcD significantly increased the magnitude of
AEA inhibition from 53  11% to 88  2% (Fig. 4B; p 
 0.02,
unpaired t test, n  7).
AEA Inhibition Correlated with Mean Current Den-
sity. The above observations indicate that potency of AEA
inhibition of 5-HT3A receptor function depends on receptor
steady-state density at the cell surface. However, one can
argue if this phenomenon occurs exclusively in X. laevis
oocytes, where a slow perfusion system is used. To answer
this question, we performed whole-cell recordings combined
with fast drug perfusion to examine the effect of AEA on the
5-HT3A subunits expressed in HEK 293 cells. In cells tran-
siently expressing 5-HT3A receptors, the amplitude of cur-
rent activated by maximal 5-HT (100 M) varied from 0.3 to
7.9 nA, indicating that the levels of receptor expression differ
substantially at the surface of individual cells. AEA inhibited
current amplitude activated by 30 M 5-HT. The magnitudes
of average percentage inhibition by 0.1 and 1 M AEA were
58  3% and 92  2%. These data are in line with a previous
study (Barann et al., 2000). Similar to the observations in
oocyte experiments, HEK cells that exhibited relatively low
current amplitudes were more sensitive to AEA than those
that exhibited high-current amplitudes (Fig. 5A). We then
calculated MCD by plotting maximal 5-HT current ampli-
tude over capacitance of each individual cell. The extent of
MCD was inversely correlated with the percentage of AEA
inhibition of current peak (Fig. 5B; linear regression, p 

0.01, n 13) and current area (Fig. 5C; linear regression, p

0.01, n  13).
AEA Did Not Affect 5-HT3A Receptor Trafficking. The
AEA inhibition develops slowly and requires a preincubation
of AEA to reach the maximal effect. This observation
prompted us to ask whether AEA inhibits 5-HT3 receptors by
Fig. 2. AEA inhibition depends on expression level of receptor proteins at
the cell surface. A, Western blot of 5-HT3A receptor protein at the surface
membrane of X. laevis oocytes. A representative gel of Western blot
showing the abundance of surface proteins from cells previously injected
with various concentrations of 5-HT3A receptor cRNAs. B, tracing records
showing AEA inhibition of 5-HT-activated currents in cells previously
injected with 2.5 ng (top) and 50 ng (bottom) 5-HT3A receptor cRNAs. C,
time course of AEA inhibition of I5-HT in X. laevis oocytes previously
injected with 1, 20, and 50 ng of the 5-HT3A receptor cRNAs. The solid bar
indicates the time of AEA application. Each data point represents
mean  S.E. from the average of five cells. D, concentration-response
curves of AEA inhibition of 5-HT-activated current in cells previously
injected with 1, 2.5, and 50 ng of 5-HT3A receptor cRNAs. The curves were
best fit to the Hill equation as described under Materials and Methods.
Each data point represents mean  S.E. from at least 5 oocytes
Fig. 3. AEA inhibition correlates with levels of receptor expression. A,
correlation between the magnitude of inhibitory effect induced by 10 M
AEA and various concentrations of 5-HT3A receptor cRNAs injected into
oocytes (linear regression, p 
 0.0001, n  6). Each data point represents
mean  S.E. from at least seven oocytes. B, correlation between the
magnitude of AEA inhibition and levels of surface 5-HT3A receptor pro-
teins isolated from oocytes previously injected with various concentra-
tions of 5-HT3A receptor cRNA (linear regression, p 
 0.001, n  5). Each
data point represents mean  S.E. from three separate experiments. The
band density was normalized as a percentage of control. C, correlation
between the extent of AEA-induced inhibiting effect on 5-HT3A receptors
and current amplitude activated by maximal concentration of 5-HT (100
M) in oocytes previously injected with 1, 10, and 25 ng of 5-HT3A
receptor cRNA (linear regression, p 
 0.01, n  24). These data were
collected from the same batch of oocytes.
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modulating receptor internalization. We first examined the
effect of AEA on 5-HT3A receptor trafficking in living HEK
293 cells that express 5-HT3A receptor proteins tagged on the
extracellular amino and carboxyl terminus with a -bunga-
rotoxin pharmatope (BTX). The 13-amino acid BTX phar-
matope is derived from the nACh receptor. The BTX phar-
matope-tagged receptors can be labeled by BTX, which allows
us to specifically label surface receptors and to visualize
receptor trafficking in living cells. Cells were labeled with
tetramethylrhodamine-BTX (red) before exposure to AEA
and then treated with 2 M AEA for 5 min. These cells were
then labeled with Alexa Fluor-488-BTX (green). Under this
experimental procedure, the receptors that were endocytosed
during AEA incubation period were observed as red signal
within interior of cells. Those Alexa Fluor-488 labeled-recep-
tors that did not enter endocytosis were double-labeled and
appeared as yellow signal surround cell perimeter, whereas
those that appeared in green may represent newly inserted
channels. Figure 6A illustrates double-labeling of 5-HT3A
receptors without and with 2 M AEA. The majority of the
5-HT3A receptors that were on the cell’s surface during the
initial period had been endocytosed in the absence and pres-
ence of AEA. Next, we used a protein biotinylation-labeling
method to quantitatively evaluate surface expression of
5-HT3A receptor proteins. The density of the surface protein
revealed by Western blot seemed to be similar before and 5,
10, and 20 min after AEA administration (Fig. 6B). The
average values of protein gel intensity measured were 97 
10%, 110  14%, and 104  12% of control (Fig. 6C). These
values were not significantly different (Fig. 6C; p 	 0.5,
ANOVA).
AEA Accelerated Receptor Desensitization. To ex-
plore the mechanisms that underlie AEA inhibition of
5-HT3A receptors, we conducted kinetic analysis using fast
drug perfusion. Although AEA did not significantly alter the
10% to 30% rise time of 5-HT-activated currents (2.9  0.1
versus 3.1  0.1 ms, unpaired t test, p  0.2), AEA seemed to
accelerate the desensitization decay of 5-HT-activated cur-
rent (Fig. 7A) in the prolonged presence of 5-HT (“desensiti-
zation”). To properly evaluate the desensitization kinetics,
we normalized the fast and slow components using the
weighted sum formula described under Materials and Meth-
ods. We first examined the effect of AEA on the time courses
of 5-HT-activated current (F) and receptor desensitization
(E). Both AEA-induced inhibition and desensitization devel-
oped in similar time courses. However, the receptor desensi-
tization reached the maximal extent after preincubation of
AEA for 2 min, whereas the maximal extent of AEA inhibi-
tion required 5 min (Fig. 7B). The weighted sum of the
desensitization time constant components for 5-HT alone was
536  87 ms, whereas the weighted sum of the desensitiza-
tion time constants in the presence of 0.03 and 0.1 M AEA
were 386  68 and 76  17 ms, respectively. These values
were significantly different from that of control (Fig. 7C; p 

0.01, ANOVA). In contrast, AEA did not significantly affect
the deactivation time course, which was also best fit by a
biexponential function. The deactivation time constants of
the fast decay component averaged 0.12  0.01 and 0.13 
0.01 s with and without AEA, respectively. The deactivation
Fig. 4. AcD treatment decreases I5-HT and increases AEA inhibition of
5-HT3A receptors. A, bar graphs of average amplitude of current induced
by maximal concentration of 5-HT (100 M) without and with AcD
treatment of X. laevis oocytes expressing mouse 5-HT3A receptors. B, bar
graphs represent average percentage of AEA inhibition of 5-HT3A recep-
tors without and with AcD treatment. Each data point represents mean
S.E. from five cells.  indicates a significant difference compared with
control (p 
 0.02).
Fig. 5. AEA inhibition correlates with 5-HT3A receptor density expressed
in HEK 293 cells. A, representative current records show low- and high-
density currents induced by 30 M 5-HT in the absence and presence of
0.1 M AEA in HEK 293 cells transiently transfected with the cDNA of
human 5-HT3A receptors. AEA was preapplied to a cell for 2 min before
application of 5-HT. B, correlation between the percentage AEA inhibi-
tion of current amplitude and MCD (linear regression, p 
 0.01, n  12).
C, correlation between the percentage AEA inhibition of current area and
MCD (linear regression, p 
 0.01, n  12).
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time constants of the slow component averaged 1.9  0.1 and
1.6  0.2 s in the absence and presence of AEA, respectively.
These values were not significantly different (p 	 0.2, un-
paired t test, n  12). A previous study showed that AEA
bound to bovine serum albumin (BSA) (Bojesen and Hansen,
2003). A recent study has reported that BSA can accelerate
the recovery time of AEA inhibition of nACh42 subunits
(Spivak et al., 2007). In view of these findings, we applied
0.3% of BSA during washout time of AEA-induced inhibition.
We observed that BSA accelerated the recovery time after
AEA inhibition. For instance, the average recovery rates of
I5-HT after AEA inhibition were 42 3 and 59 6% of control
current without and with BSA 2 min after AEA application.
These values were significant different (p 
 0.01, unpaired t
test, n  6).
Receptor Desensitization Was Correlated with MCD.
The above observations suggest that AEA accelerates recep-
tor desensitization. Given the observation that MCD was
correlated with AEA inhibition, we predicted that MCD
would also correlate with receptor desensitization. This was
proved to be the case when a strong correlation was observed
between MCD and desensitization time (Fig. 8A; linear re-
gression, p 
 0.001). MCD was also correlated with percent-
age inhibition by AEA (Fig. 8B; linear regression, p 
 0.001,
n  15). However, no significant correlation was observed
between receptor activation/deactivation and MCD (Fig. 8, C
and D; p 	 0.5, n  15).
5-HTID and NOC Slowed Receptor Desensitization
and Reduced AEA-Induced Inhibiting Effect on 5-HT3A
Receptors. To further explore the mechanism of AEA inhi-
bition, we designed the following experiments. First, we pre-
treated cells with 25 M NOC, a microtubule disruptor, for
4 h before electrophysiological recording of 5-HT-activated
current. A recent study from our laboratory has shown that
disruption of microtubule by NOC can significantly slow
mouse 5-HT3 receptor desensitization (Emerit et al., 2005).
Consistent with this study, NOC treatment slowed the decay
of 5-HT-activated current in HEK 293 cells expressing hu-
man 5-HT3A receptors (Fig. 9A). Another approach we used
was 5-HTID, which has been shown to slow 5-HT3 receptor
desensitization (van Hooft et al., 1997; Gunthorpe and Lum-
mis, 1999). Simultaneous application of 5-HTID at 5 mM
Fig. 6. AEA does not alter receptor trafficking. A, imaging of live HEK
293 cells expressing 5-HT3A receptor-BTX in the absence and presence of
2 M AEA. Alexa Fluor 488-BTX was first incubated with a cell before 2
M AEA in red. The cell was labeled with a secondary staining of
tetramethylrhodamine-BTX after AEA in green. B, a representative
Western blot of 5-HT3A receptor surface proteins expressed in X. laevis
oocytes. C, bar graphs represent normalized gel intensity (percentage of
control) of 5-HT3A receptor proteins isolated from cell surface of oocytes in
the absence (control) and presence of 2 M AEA. Each data point repre-
sents mean  S.E. from at least three separate experiments.
Fig. 7. AEA accelerates receptor desensitization kinetics. A, tracings of
5-HT-activated currents without and with 0.1 M AEA recorded from a
HEK 293 cell expressing human 5-HT3A receptors. The amplitude of
current in the presence of AEA was normalized. B, the effect of AEA on
the time courses of 5-HT-activated current and receptor desensitization.
On the graph, F indicates average percentage 5-HT current amplitude
(during AEA incubation) as average percentage of control (amplitude of
5-HT current before AEA); E indicates desensitization time during AEA
incubation as average percentage of control (desensitization time before
AEA). Each data point represents mean  S.E. from five individual HEK
293 cells. C, bar graphs represent the average desensitization time of fast
components (left) with and without 0.1 M AEA. Bar graphs (right)
represent the sums of fast and slow components of 5-HT3A receptor
kinetics without and with AEA. Each data point represents mean  S.E.
from 11 HEK 293 cells.  indicates a significant difference compared with
control (p 
 0.001).
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with 5-HT slowed the decay of 5-HT-activated current (Fig.
9A). Pretreatment of HEK 293 cells with NOC and 5-HTID
slowed 5-HT3A receptor desensitization time by6-fold (solid
bars) and, on the other hand, significantly reduced the aver-
age percentage of AEA inhibition from 54  3% (control) to
33 2% and 27 6% (Fig. 9B; open bars). These values were
significantly different (p 
 0.01, ANOVA, n  11). The MCD
induced by maximal concentration of 5-HT were 0.22  0.04,
0.26  0.05, and 0.18  0.04 nA/pF in the absence (control)
and presence of NOC and 5-HTID (Fig. 9C). These values
were not significantly different (ANOVA, p	 0.2, n 14–22).
Discussion
Our data presented in this study indicate that the sensi-
tivity of 5-HT3 receptors to AEA-induced inhibiting effect
depends on steady-state receptor density at the cell surface.
We have shown that surface protein and functional expres-
sion of the 5-HT3A receptors were correlated with the extent
of AEA inhibition in X. laevis oocyte and HEK 293 cells
expressing 5-HT3A receptors. A reduction in the functional
expression of 5-HT3A receptors induced by AcD treatment
increased the sensitivity of 5-HT3A receptors to AEA-induced
inhibition. It should be noted that the correlation observed in
X. laevis oocytes was more dramatic than that of HEK 293
cells. This difference exists because the expression levels of
5-HT3A receptor protein can be readily manipulated in X.
laevis oocytes. For instance, we injected oocytes with various
concentrations of cRNA over a range from 1 to 75 ng. As a
result, we observed a difference in the maximal current am-
plitudes by nearly 350-fold (200–7000 nA). However, the
difference of the maximal current amplitude was only 10-fold
(200–7000 pA) in HEK 293 cells transiently transfected with
5-HT3A receptor cDNA.
Our results also suggest that receptor density contributes
to receptor desensitization, which is the key factor determin-
ing the sensitivity of 5-HT3A receptors to AEA-induced inhi-
bition. This is evidenced by our observation that both NOC
and 5-HTID reduced both receptor desensitization and AEA
inhibition without significantly changing maximal 5-HT cur-
rent amplitude. We propose that the low-density 5-HT3A
receptors at the cell surface should be more efficient than the
high-density receptors to enter the desensitized state when
exposed to agonist or agonist plus AEA. This idea is sup-
ported by a recent study from our laboratory that 5-HT3A
receptor desensitization is regulated by the light chain of the
microtubule-associated protein 1B (LC1) (Emerit et al.,
2005). In this case, MAP1B-LC1 reduces steady state recep-
tor density at the cell surface and accelerates receptor desen-
sitization kinetics at the steady state. Consistent with our
Fig. 8. Receptor desensitization correlates with MCD and AEA inhibi-
tion. A, correlation between 5-HT MCD and receptor desensitization time
(linear regression, p 
 0.01). B, correlation between average percentage
AEA inhibition and receptor desensitization time (linear regression, p 

0.01). C, correlation analysis of 5-HT MCD and receptor activation time
(linear regression, p  0.4). D, correlation analysis of 5-HT MCD and the
fast (f) and slow () components of receptor deactivation kinetics (linear
regression, p  0.5).
Fig. 9. The effects of NOC and 5-HTID on receptor desensitization and
AEA inhibition. A, tracings of 5-HT-activated currents without and with
NOC and 5-HTID in HEK 293 cells expressing human 5-HT3A receptors.
Cells were pretreated with 25 MNOC for 4 h and washed thoroughly by
perfusion solution during the recording. 5-HTID was applied with 5-HT
simultaneously. B, the open bars represent the average percentage inhi-
bition induced by 0.1 M AEA. The solid bars represent average desen-
sitization time with and without 0.1 M AEA. The average time constant
of receptor desensitization is the sum of fast and slow components of
5-HT3A receptor kinetics without and with AEA. Each data point repre-
sents mean  S.E. from 11 cells.  indicates a significant difference
compared with control (p 
 0.02).  indicates a significant difference
compared with control (p 
 0.001). C, bar graphs of the calculated MCD
in the absence and presence of NOC and 5-HTID. Each data point rep-
resents mean  S.E. from 14 to 22 cells
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hypothesis, the steady state density of GABAA receptors at
the cell surfaces has also been found to critically regulate
receptor desensitization (Chen et al., 2000; Petrini et al.,
2003; Boileau et al., 2005). Likewise, there is a study showing
that desensitization of glycine receptors varies with receptor
density (Legendre et al., 2002). It should be pointed out that,
in addition to receptor density, many other factors contribute
to receptor desensitization. These physiological modulators
include external calcium concentration (Hu and Lovinger,
2005), post-translational modification of the receptor pro-
tein (Yakel and Jackson, 1988) and subunit composition
(Hapfelmeier et al., 2003). Future experiments are awaited to
determine how the factors listed above regulate AEA-induced
inhibiting effect on 5-HT3 receptors.
AEA seems to selectively alter 5-HT3A receptor desensiti-
zation kinetics without changing activation and deactivation
kinetic properties. This observation is consistent with a pre-
vious study showing that AEA does not alter the specific
binding of the 5-HT3 receptor antagonist [
3H]GR65630 in
HEK 293 cells expressing 5-HT3A receptors (Barann et al.,
2002). AEA belongs to a group of signaling lipids that can
bind proteins through a hydrogen-bonding-like interaction
(Bojesen and Hansen, 2003). It is plausible to predict that
AEA reduces current amplitude by lowering the energy bar-
rier for receptors to enter a desensitized state. Conversely,
5-HT3A receptor density at the steady state contributes to the
free energy barrier required for conformational changes dur-
ing a receptor desensitization process. It should be pointed
out that AEA is unlikely to be an open channel blocker (OCB)
at 5-HT3 receptors for the following reasons. First, the inhib-
itory effect of AEA on 5-HT3A receptors was not voltage-
dependent (Fan, 1995; Oz et al., 2002). Second, AEA acceler-
ated receptor desensitization in a concentration dependent
manner, whereas a typical OCB usually slows receptor de-
sensitization with increasing its concentrations. Third, AEA
became less potent to inhibit 5-HT3A receptors when receptor
desensitization was slowed after NOC and 5-HTID treat-
ment, whereas an OCB should be more potent to act at a
receptor when its desensitization slows.
LGICs constantly move in and out of synaptic membrane
surfaces under various physiological and pathological con-
ditions (Moss and Smart, 2001). Such dynamic receptor
trafficking is essential for synaptic transmission and plas-
ticity (Sheng and Pak, 2000). Multiple factors can contrib-
ute to the regulation of receptor density at synaptic mem-
brane surfaces. Expression levels of 5-HT3A receptors can
be mediated through mechanisms that involve activation
of protein kinases (Sun et al., 2003), cytoskeleton proteins
(Emerit et al., 2005), naturally occurring genetic variants
(Niesler et al., 2001a) and abused drugs such as alcohol
(Ciccocioppo et al., 1998). In addition, the expression of
these receptors is increased in serotonin transporter defi-
cient mice, suggesting that the extracellular concentration
of 5-HT may also influence receptor density (Mo¨ssner et
al., 2004). Cannabinoids and endocannabinoids exert (in
addition to psychotropic effects) strong antinociceptive and
antiemetic effects (Pacher et al., 2006). Coincidentally,
selective 5-HT3 receptor antagonists are also known to
effectively control pain and emesis (Zhang and Lummis,
2006). It should be interesting for future studies to deter-
mine the physiological and therapeutic significance of AEA
inhibition of 5-HT3 receptors in human and animal models.
We conclude that 5-HT3 receptor steady-state density de-
termines receptor desensitization kinetics and the sensitivity
of the receptor to the inhibitory effect of AEA. Such a mech-
anism seems to account for the variability in AEA inhibition
of 5-HT3 receptors expressed in different neurons and cell
lines. This mechanism could also be applicable to the inhib-
itory effect of AEA on the other members of LGICs such as
nACh and glycine receptors because AEA has been found to
accelerate receptor desensitization kinetics in a manner sim-
ilar to that observed in 5-HT3 receptors (Lozovaya et al.,
2005; Spivak et al., 2007).
Acknowledgments
We thank Drs. David Julius (University of California at San
Francisco, San Francisco, CA) and Sarah S. C. Lummis (Cambridge
University, Cambridge, UK) for kindly providing the cDNA clones of
mouse 5-HT3 receptor and polyclonal 5-HT3A receptor antiserum. We
thank Dr. David M. Lovinger for comments on the manuscript. We
also thank Guoxiang Lou for constructing 5-HT3AR-BTX.
References
Adams IB, Compton DR, and Martin BR (1998) Assessment of anandamide interac-
tion with the cannabinoid brain receptor: SR 141716A antagonism studies in mice
and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp
Ther 284:1209–1217.
Barann M, Meder W, Dorner Z, Bruss M, Bonisch H, Gothert M, and Urban BW
(2000) Recombinant human 5-HT3A receptors in outside-out patches of HEK 293
cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Phar-
macol 362:255–265.
Barann M, Molderings G, Bruss M, Bonisch H, Urban BW, and Gothert M (2002)
Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involve-
ment of an allosteric modulatory site. Br J Pharmacol 137:589–596.
Barnes JM, Barnes NM, Costall B, Ironside JW, and Naylor RJ (1989) Identification
and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain
tissue. J Neurochem 53:1787–1793.
Boileau AJ, Pearce RA, and Czajkowski C (2005) Tandem subunits effectively con-
strain GABAA receptor stoichiometry and recapitulate receptor kinetics but are
insensitive to GABAA receptor-associated protein. J Neurosci 25:11219–11230.
Bojesen IN and Hansen HS (2003) Binding of anandamide to bovine serum albumin.
J Lipid Res 44:1790–1794.
Chen L, Wang H, Vicini S, and Olsen RW (2000) The gamma-aminobutyric acid type
A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor
clustering and modulates the channel kinetics. Proc Natl Acad Sci U S A 97:
11557–11562.
Ciccocioppo R, Ge J, Barnes NM, and Cooper SJ (1998) Central 5-HT3 receptors in
P and in AA alcohol-preferring rats: An autoradiographic study. Brain Res Bull
46:311–315.
Emerit MB, Sun H, Hu X-Q, Schoenebeck JC, Peoples RW, Miko A, Williams CK, and
Zhang L (2005) 5-HT3 receptor linkage to cytoskeleton by MAP1B determines
receptor desensitization kinetics. Soc Neurosci Abstr 31:844.17.
Engel SR and Allan AM (1999) 5-HT3 receptor over-expression enhances ethanol
sensitivity in mice. Psychopharmacology (Berl) 144:411–415.
Engel SR, Lyons CR, and Allan AM (1998) 5-HT3 receptor over-expression decreases
ethanol self administration in transgenic mice. Psychopharmacology (Berl) 140:
243–248.
Fan P (1995) Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat
nodose ganglion neurons. J Neurophysiol 73:907–910.
Gunthorpe MJ and Lummis SC (1999) Diltiazem causes open channel block of
recombinant 5-HT3 receptors. J Physiol 519:713–722.
Hapfelmeier G, Tredt C, Haseneder R, Zieglgansberger W, Eisensamer B, Rupprecht
R, and Rammes G (2003) Co-expression of the 5-HT3B serotonin receptor subunit
alters the biophysics of the 5-HT3 receptor. Biophys J 84:1720–1733.
Harrell AV and Allan AM (2003) Improvements in hippocampal-dependent learning
and decremental attention in 5-HT(3) receptor overexpressing mice. Learn Mem
10:410–419.
Hejazi N, Zhou C, Oz M, Sun H, Ye JH, and Zhang L (2006) 32 9-Tetrahydrocan-
nabinol and endogenous cannabinoid anandamide directly potentiate the function
of glycine receptors. Mol Pharmacol 69:991–997.
Hollmann M, Maron C, and Heinemann S (1994) N-Glycosylation site tagging
suggests a three transmembrane domain topology for the glutamate receptor
GluR1. Neuron 13:1331–1343.
Hu XQ and Lovinger DM (2005) Role of aspartate 298 in mouse 5-HT3A receptor
gating and modulation by extracellular Ca2. J Physiol 568:381–396.
Hu XQ, Sun H, Peoples RW, Hong R, and Zhang L (2006) An interaction involving an
arginine residue in the cytoplasmic domain of the 5-HT3A receptor contributes to
receptor desensitization mechanism. J Biol Chem 281:21781–21788.
Iidaka T, Ozaki N, Matsumoto A, Nogawa J, Kinoshita Y, Suzuki T, Iwata N,
Yamamoto Y, Okada T, and Sadato N (2005) A variant C178T in the regulatory
region of the serotonin receptor gene HTR3A modulates neural activation in the
human amygdala. J Neurosci 25:6460–6466.
Anandamide Inhibition of 5-HT3A Receptors 321
 at A
SPET Journals on N
ovem
ber 7, 2014
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
Krzywkowski K (2006) Do polymorphisms in the human 5-HT3 genes contribute to
pathological phenotypes? Biochem Soc Trans 34:872–876.
Krzywkowski K, Jensen AA, Connolly CN, and Brauner-Osborne H (2007) Naturally
occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor
function and expression. Pharmacogenet Genomics 17:255–266.
Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda RC, Zheng X, Bennett
MV, and Zukin RS (2001) Protein kinase C modulates NMDA receptor trafficking
and gating. Nat Neurosci 4:382–390.
Legendre P, Muller E, Badiu CI, Meier J, Vannier C, and Triller A (2002) Desensi-
tization of homomeric alpha1 glycine receptor increases with receptor density.Mol
Pharmacol 62:817–827.
Lozovaya N, Yatsenko N, Beketov A, Tsintsadze T, and Burnashev N (2005) Glycine
receptors in CNS neurons as a target for nonretrograde action of cannabinoids.
J Neurosci 25:7499–7506.
Melke J, Westberg L, Nilsson S, Landen M, Soderstrom H, Baghaei F, Rosmond R,
Holm G, Bjorntorp P, Nilsson LG, et al. (2003) A polymorphism in the serotonin
receptor 3A (HTR3A) gene and its association with harm avoidance in women.
Arch Gen Psychiatry 60:1017–1023.
Morales M and Bloom FE (1997) The 5-HT3 receptor is present in different subpopu-
lations of GABAergic neurons in the rat telencephalon. J Neurosci 17:3157–3167.
Morales M and Wang SD (2002) Differential composition of 5-hydroxytryptamine3
receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci
22:6732–6741.
Moss SJ and Smart TG (2001) Constructing inhibitory synapses. Nat Rev Neurosci
2:240–250.
Mo¨ssner R, Schmitt A, Hennig T, Benninghoff J, Gerlach M, Riederer P, Deckert J,
and Lesch KP (2004) Quantitation of 5HT3 receptors in forebrain of serotonin
transporter deficient mice. J Neural Transm 111:27–35.
Niesler B, Flohr T, Nothen MM, Fischer C, Rietschel M, Franzek E, Albus M,
Propping P, and Rappold GA (2001a) Association between the 5 UTR variant
C178T of the serotonin receptor gene HTR3A and bipolar affective disorder.
Pharmacogenetics 11:471–475.
Niesler B, Weiss B, Fischer C, Nothen MM, Propping P, Bondy B, Rietschel M, Maier
W, Albus M, Franzek E, et al. (2001b) Serotonin receptor gene HTR3A variants in
schizophrenic and bipolar affective patients. Pharmacogenetics 11:21–27.
Oz M, Ravindran A, Diaz-Ruiz O, Zhang L, and Morales M (2003) The endogenous
cannabinoid anandamide inhibits 7 nicotinic acetylcholine receptor-mediated
responses in Xenopus oocytes. J Pharmacol Exp Ther 306:1003–1010.
Oz M, Zhang L, andMorales M (2002) Endogenous cannabinoid, anandamide, acts as
a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus
oocytes. Synapse 46:150–156.
Pacher P, Batkai S, and Kunos G (2006) The endocannabinoid system as an emerg-
ing target of pharmacotherapy. Pharmacol Rev 58:389–462.
Petrini EM, Zacchi P, Barberis A, Mozrzymas JW, and Cherubini E (2003) Declus-
terization of GABAA receptors affects the kinetic properties of GABAergic currents
in cultured hippocampal neurons. J Biol Chem 278:16271–16279.
Pratt GD, Bowery NG, Kilpatrick GJ, Leslie RA, Barnes NM, Naylor RJ, Jones BJ,
Nelson DR, Palacids JM, Slater P, et al. (1990) Consensus meeting agrees distri-
bution of 5-HT3 receptors in mammalian hindbrain. Trends Pharmacol Sci 11:
135–137.
Sheng M and Pak DT (2000) Ligand-gated ion channel interactions with cytoskeletal
and signaling proteins. Annu Rev Physiol 62:755–778.
Spier AD, Wotherspoon G, Nayak SV, Nichols RA, Priestley JV, and Lummis SC
(1999) Antibodies against the extracellular domain of the 5-HT3 receptor label
both native and recombinant receptors. Brain Res Mol Brain Res 67:221–230.
Spivak CE, Lupica CR, and Oz M (2007) The endocannabinoid anandamide inhibits
the function of 42 nicotinic acetylcholine receptors. Mol Pharmacol 72:1024–
1032.
Sun H, Hu XQ, Moradel EM, Weight FF, and Zhang L (2003) Modulation of 5-HT3
receptor-mediated response and trafficking by activation of protein kinase C.
J Biol Chem 278:34150–34157.
Tecott LH, Maricq AV, and Julius D (1993) Nervous system distribution of the
serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci U S A 90:1430–1434.
van Hooft JA, van der Haar E, and Vijverberg HP (1997) Allosteric potentiation of
the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells by
5-hydroxyindole and analogues. Neuropharmacology 36:649–653.
Waeber C, Dixon K, Hoyer D, and Palacios JM (1988) Localisation by autoradiogra-
phy of neuronal 5-HT3 receptors in the mouse CNS. Eur J Pharmacol 151:351–
352.
Waeber C, Hoyer D, and Palacios JM (1989) 5-hydroxytryptamine3 receptors in the
human brain: autoradiographic visualization using [3H]ICS 205–930. Neuro-
science 31:393–400.
Waeber C, Pinkus LM, and Palacios JM (1990) The (S)-isomer of [3H]zacopride labels
5-HT3 receptors with high affinity in rat brain. Eur J Pharmacol 181:283–287.
Yakel JL and Jackson MB (1988) 5-HT3 receptors mediate rapid responses in
cultured hippocampus and a clonal cell line. Neuron 1:615–621.
Zhang L and Lummis SC (2006) 5-HT3 receptors, in Allosteric Receptor Modulation
in Drug Targeting (Bowery NG ed) pp 135–154, Taylor & Francis, New York.
Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, and Bonner TI (1999) In-
creased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor
knockout mice. Proc Natl Acad Sci U S A 96:5780–5785.
Address correspondence to: Dr. Li Zhang, Laboratory for Integrative Neu-
roscience National Institute on Alcohol Abuse and Alcoholism, National Insti-
tutes of Health, 5625 Fishers Lane, Bethesda, MD 20892. E-mail: lzhang@
mail.nih.gov
322 Xiong et al.
 at A
SPET Journals on N
ovem
ber 7, 2014
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
